Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price Down 3.2%

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded down 3.2% on Monday . The stock traded as low as $18.21 and last traded at $18.34. 146,579 shares were traded during trading, a decline of 79% from the average session volume of 706,325 shares. The stock had previously closed at $18.94. Wall Street […]

Related Keywords

, Melissab Epperly , Jan Skvarka , Matrix Capital Management Company , Zentalis Pharmaceuticals Stock Performance , Institutional Trading Of Zentalis Pharmaceuticals , Nasdaq , Blackrock Inc , News Ratings For Zentalis Pharmaceuticals Daily , Zentalis Pharmaceuticals Company Profile , Zentalis Pharmaceuticals , Wells Fargo Company , Eventide Asset Management , Zentalis Pharmaceuticals Inc , Pricet Rowe Associates Inc , Securities Exchange Commission , Get Free Report , Director Jan Skvarka , Exchange Commission , Capital Management Company , Asset Management , Zentalis Pharmaceuticals Daily , Nasdaq Zntl , Zntl , Medical , Stocks , Technicals ,